Skip to content
Disclosery

Hyperion Capital Advisors LP: GMED position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Hyperion Capital Advisors LP on GMED, newest first. How the timeline and the estimate are built.

Hyperion Capital Advisors LP held 71,476 GMED shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 71,476 shares
    Change vs previous 13F -69,373 shares

    2.55% of the 13F portfolio, value $5,647,319.

    13F-HR 0000919574-26-005177 filed by Hyperion Capital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 140,849 shares
    Change vs previous 13F -6,008 shares

    5.84% of the 13F portfolio, value $12,135,550.

    13F-HR 0000919574-26-003130 filed by Hyperion Capital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 146,857 shares
    Change vs previous 13F not available

    6.28% of the 13F portfolio, value $12,822,085.

    13F-HR 0000919574-26-000774 filed by Hyperion Capital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).